Banini, M.; Salvestrini, V.; Vultaggio, A.; Perlato, M.; Mecheri, V.; Cerbai, C.; Scotti, V.; Matucci, A.; Mangoni, M.; Livi, L.;
et al. Desensitization Protocol for Cemiplimab-Related Infusion Reaction in Cutaneous Squamous Cell Carcinoma: A Case Report and Literature Review. Curr. Oncol. 2023, 30, 6699-6707.
https://doi.org/10.3390/curroncol30070491
AMA Style
Banini M, Salvestrini V, Vultaggio A, Perlato M, Mecheri V, Cerbai C, Scotti V, Matucci A, Mangoni M, Livi L,
et al. Desensitization Protocol for Cemiplimab-Related Infusion Reaction in Cutaneous Squamous Cell Carcinoma: A Case Report and Literature Review. Current Oncology. 2023; 30(7):6699-6707.
https://doi.org/10.3390/curroncol30070491
Chicago/Turabian Style
Banini, Marco, Viola Salvestrini, Alessandra Vultaggio, Margherita Perlato, Valentina Mecheri, Cecilia Cerbai, Vieri Scotti, Andrea Matucci, Monica Mangoni, Lorenzo Livi,
and et al. 2023. "Desensitization Protocol for Cemiplimab-Related Infusion Reaction in Cutaneous Squamous Cell Carcinoma: A Case Report and Literature Review" Current Oncology 30, no. 7: 6699-6707.
https://doi.org/10.3390/curroncol30070491
APA Style
Banini, M., Salvestrini, V., Vultaggio, A., Perlato, M., Mecheri, V., Cerbai, C., Scotti, V., Matucci, A., Mangoni, M., Livi, L., & Bonomo, P.
(2023). Desensitization Protocol for Cemiplimab-Related Infusion Reaction in Cutaneous Squamous Cell Carcinoma: A Case Report and Literature Review. Current Oncology, 30(7), 6699-6707.
https://doi.org/10.3390/curroncol30070491
